Parsad R, Ahlawat S, Bagiyal M, Arora R, Gera R, Chhabra P
Mamm Genome. 2024; 36(1):151-161.
PMID: 39738581
DOI: 10.1007/s00335-024-10101-z.
Jan-Ngam V, Boontha S, Tubsuwan A, Wongpalee S, Fanhchaksai K, Tantiworawit A
Heliyon. 2024; 10(18):e38020.
PMID: 39381253
PMC: 11459010.
DOI: 10.1016/j.heliyon.2024.e38020.
Borsani O, Varettoni M, Riccaboni G, Rumi E
Front Med (Lausanne). 2024; 11:1419092.
PMID: 39188884
PMC: 11345742.
DOI: 10.3389/fmed.2024.1419092.
Ferens F, Taber C, Stuart S, Hubert M, Tarade D, Lee J
Commun Biol. 2024; 7(1):240.
PMID: 38418569
PMC: 10902354.
DOI: 10.1038/s42003-024-05904-4.
Lawrence E, Gu W, Bohlender R, Anza-Ramirez C, Cole A, Yu J
Sci Adv. 2024; 10(6):eadj5661.
PMID: 38335297
PMC: 10857371.
DOI: 10.1126/sciadv.adj5661.
Targeting hypoxia-inducible factors: therapeutic opportunities and challenges.
Yuan X, Ruan W, Bobrow B, Carmeliet P, Eltzschig H
Nat Rev Drug Discov. 2023; 23(3):175-200.
PMID: 38123660
DOI: 10.1038/s41573-023-00848-6.
Hypoxia Inducible Factor pathway proteins in high-altitude mammals.
Lee F
Trends Biochem Sci. 2023; 49(1):79-92.
PMID: 38036336
PMC: 10841901.
DOI: 10.1016/j.tibs.2023.11.002.
Origin and functional diversification of PAS domain, a ubiquitous intracellular sensor.
Xing J, Gumerov V, Zhulin I
Sci Adv. 2023; 9(35):eadi4517.
PMID: 37647406
PMC: 10468136.
DOI: 10.1126/sciadv.adi4517.
Genome editing and cancer therapy: handling the hypoxia-responsive pathway as a promising strategy.
Stampone E, Bencivenga D, Capellupo M, Roberti D, Tartaglione I, Perrotta S
Cell Mol Life Sci. 2023; 80(8):220.
PMID: 37477829
PMC: 10361942.
DOI: 10.1007/s00018-023-04852-2.
High-Altitude Andean H194R HIF2A Allele Is a Hypomorphic Allele.
Jorgensen K, Song D, Weinstein J, Garcia O, Pearson L, Inclan M
Mol Biol Evol. 2023; 40(7).
PMID: 37463421
PMC: 10370452.
DOI: 10.1093/molbev/msad162.
Pacak-Zhuang syndrome: a model providing new insights into tumor syndromes.
Rosenblum J, Wang H, Nazari M, Zhuang Z, Pacak K
Endocr Relat Cancer. 2023; 30(10).
PMID: 37450881
PMC: 10512798.
DOI: 10.1530/ERC-23-0050.
Structural basis for binding of the renal carcinoma target hypoxia-inducible factor 2α to prolyl hydroxylase domain 2.
Figg Jr W, Fiorini G, Chowdhury R, Nakashima Y, Tumber A, McDonough M
Proteins. 2023; 91(11):1510-1524.
PMID: 37449559
PMC: 10952196.
DOI: 10.1002/prot.26541.
Vascular stiffening in aging females with a hypertension-induced HIF2A gain-of-function mutation.
Volkova E, Procell L, Kong L, Santhanam L, Gerecht S
Bioeng Transl Med. 2023; 8(2):e10403.
PMID: 36925716
PMC: 10013765.
DOI: 10.1002/btm2.10403.
Updates on Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in the Treatment of Renal Anemia.
Li J, Haase V, Hao C
Kidney Dis (Basel). 2023; 9(1):1-11.
PMID: 36756084
PMC: 9900466.
DOI: 10.1159/000527835.
Comprehensive and functional studies for classification of genetic variants identified in patients with erythrocytosis.
Karaghiannis V, Maric D, Garrec C, Maaziz N, Buffet A, Schmitt L
Haematologica. 2023; 108(6):1652-1666.
PMID: 36700397
PMC: 10230427.
DOI: 10.3324/haematol.2022.281698.
Hypoxia signaling pathway: A central mediator in endocrine tumors.
Watts D, Jaykar M, Bechmann N, Wielockx B
Front Endocrinol (Lausanne). 2023; 13:1103075.
PMID: 36699028
PMC: 9868855.
DOI: 10.3389/fendo.2022.1103075.
A pleiotropic hypoxia-sensitive enhancer is disrupted by adaptive alleles in Tibetans.
Gray O, Yoo J, Sobreira D, Jousma J, Witonsky D, Sakabe N
Sci Adv. 2022; 8(47):eade1942.
PMID: 36417539
PMC: 9683707.
DOI: 10.1126/sciadv.ade1942.
Genetic and immune changes in Tibetan high-altitude populations contribute to biological adaptation to hypoxia.
Bai J, Li L, Li Y, Zhang L
Environ Health Prev Med. 2022; 27:39.
PMID: 36244759
PMC: 9640738.
DOI: 10.1265/ehpm.22-00040.
Activation of γ-globin expression by hypoxia-inducible factor 1α.
Feng R, Mayuranathan T, Huang P, Doerfler P, Li Y, Yao Y
Nature. 2022; 610(7933):783-790.
PMID: 36224385
PMC: 9773321.
DOI: 10.1038/s41586-022-05312-w.
Impaired oxygen-sensitive regulation of mitochondrial biogenesis within the von Hippel-Lindau syndrome.
Li S, Li W, Yuan J, Bullova P, Wu J, Zhang X
Nat Metab. 2022; 4(6):739-758.
PMID: 35760869
PMC: 9236906.
DOI: 10.1038/s42255-022-00593-x.